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Abstract
BACKGROUND—Results from the National Health and Nutrition Examination Survey 
(NHANES) indicate that hypertension prevalence declined by 9% points from 34% in 1976–1980 
to 25% in 1999–2002 in adults 20–74 years. The purpose of this study was to estimate the impact 
on hypertension prevalence of measurement error and selected risk factors.
METHODS—Using cross-sectional survey data from NHANES, we estimated the effect on 
hypertension of incorrect blood pressure (BP) cuff size and zero end-digit preference and the effect 
of changes in the distribution of age, body mass index (BMI), sex, race-ethnicity, smoking, and 
education. The analytic sample of persons 20–74 years consisted of 11,563 from 1976–1980 and 
7,901 from 1999–2002 NHANES. Covariate-adjusted prevalences were calculated using log-linear 
regression models to produce predictive margins.
RESULTS—After adjustment to age, BMI, sex, race-ethnicity, smoking, and education, the 
prevalence difference became higher, changing from -9% (95% confidence interval (CI): −11, −6) 
to −14% (95 CI: −17, −11). After adjustment to these risk factors and correction for measurement 
error the prevalence difference was −9% (95 CI: −11, −6).
CONCLUSIONS—Measurement error, mainly from cuff size differences, inflated the temporal 
decline in hypertension prevalence. The results indicate that age, sex, race-ethnicity, smoking, or 
education did not fully explain the lower prevalence of measured hypertension in all BMI groups 
and suggest that a change in some unmeasured factor or factors contributed to the decline.
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Over the same period that saw the doubling of prevalence of obesity, the prevalence of 
hypertension in US adults declined from 34 to 25% (age-adjusted to the 2000 US 
population).1–3 For the purpose of tracking prevalence, hypertension is defined to include 
persons currently taking antihypertensive medication or having measured blood pressure 
(BP) above recommended levels thus the increased use of medication over this period does 
not explain the observed decline in hypertension prevalence.4–6 These trends emphasize the 
multifactorial nature of hypertension etiology and highlight the necessity of an evaluation of 
differences in measurement methods and changes in population distribution of demographic 
and behavioral factors. A trend analysis of hypertension in the National Health and Nutrition 
Examination Survey (NHANES) up through 1991, was more detailed than other trends 
analyses and included documentation of several important differences but did not include an 
analysis of the effect of differences on estimates.2 Ostchega and coauthors detailed training 
procedures in NHANES 1999–2000 and evaluated the effect of measurement error on mean 
BP.7 Subsequent analysis of trends in hypertension in NHANES did not include evaluation 
of methods differences.8
The goal of this work is to gain a more complete understanding of the trends in 
hypertension, using data from the NHANES surveys in 1976–1980 and 1999–2002. Previous 
work documented methodologic differences in BP determination which may have 
contributed to the observed decline in hypertension.2 The methods used in the 1976–1980 
survey were different from the most recent survey with more thorough training and more 
accurate methods being used in the 1999–2002 survey. We first estimated the impact of two 
sources of error in BP measurement for which methods differed between surveys: incorrect 
cuff size and zero end-digit preference. We then considered whether differences in 
hypertension- related factors between the surveys may have contributed to differences in the 
prevalence of hypertension in US adults in 1976–1980 compared to 1999–2002. The factors 
examined included age, sex, race-ethnicity, cigarette smoking, and body mass index (BMI).
METHODS
Study population
The NHANES used a cross-sectional design with nationally representative samples with 
interview and examination. The 1976–1980 sample included 27,801 eligible persons 6 
months–74 years, of whom 20,322 (73%) were interviewed and examined (11,864 adults 
20–74 years). A detailed description of the survey design and operation has been published 
elsewhere.9 The 1999–2002 sample included 25,316 eligible persons of all ages, of whom 
19,759 (78%) were interviewed and examined (8,817 adults 20–74 years). Detailed 
information on the survey design and operation is available at the NHANES website http://
www.cdc.gov/nchs/nhanes.htm.10,11 The analyses in the present study were restricted to 
adults 20–74 years, an age range covered in both surveys. Informed consent was obtained 
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from all participants and the protocols were approved by the NCHS Ethics Review Board for 
both surveys.
Measurements
More specific information was collected on Mexican, Hispanic, or Latino ancestry in 1999–
2002 but available information in 1976–1980 was used to create categories similar to those 
available in the 1999–2002 survey, namely non-Hispanic whites, non-Hispanic blacks, and 
other race-ethnicities.12,13
In both surveys mid-arm circumference and body weight and height were measured 
similarly following standardized procedures with calibrated equipment.9–11,14 BMI was 
calculated as weight in kg divided by height in m2. The following categories of BMI were 
used: underweight (BMI < 18.5), normal weight (BMI 18.5–22.9 and 23.0–24.9), 
overweight or preobese (BMI 25.0–27.4 and 27.5–29.9), and obese class I (BMI 30.0–32.4 
and 32.5–34.9), obese class II (35.0–37.4 and 37.5–39.9) and obese class III (BMI ≥ 40.0).15
In 1976–1980 two seated measurements were taken and in 1999–2002, three seated 
measurements were taken. In both surveys BP was measured using a mercury 
sphygmomanometer by physicians to the nearest two mm Hg. For this analysis, hypertension 
was defined using the current definition of the Joint National Committee on Prevention, 
Detection, Evaluation, and Treatment of High Blood Pressure (JNC): systolic pressure of 
140 mm Hg or higher or diastolic pressure of 90 mm Hg or higher or current treatment with 
antihypertensive medicine.16 This definition was applied to the mean of the two 
measurements in 1976–1980 and the mean of two or three measurements in 1999–2002.
In 1976–1980, the proportion of zero end digits was higher than the expected 20% in a 
uniform distribution of the five possible end digits.2 In 1999–2000 the percent of 
measurements ending in zero was close to the expected 20%.7 We adjusted BP for zero end-
digit preference using an algorithm to impute values. In each survey the mean and s.d. of the 
first systolic measurement was used to calculate the expected relative frequency of 
observations at 140 and 138 mm Hg assuming a log-normal distribution (Table 1). The 
observed data were imputed so that the relative frequency of observations at 140 and 138 
mm Hg was equal to that expected in a log-normal distribution. We randomly selected 
observations at 140 mm Hg to impute to 138 mm Hg. Diastolic pressures were adjusted in a 
similar fashion.
The definition of diastolic BP used in 1976–1980 was the level “at the point of complete 
cessation of Korotkoff sounds (fifth sound) or if no cessation occurred, at the point of 
muffling (fourth sound)” (p. 4).17 Unfortunately the data files do not include an indicator of 
whether Korotkoff V (K5) or Korotkoff IV (K4) was recorded. In contrast in 1999–2002 the 
diastolic pressure was recorded as K5. The effect of this difference is that some individuals 
in 1976–1980 might have been classified as hypertensive using K4 but would not using K5, 
thus 1976–1980 prevalence might be higher because of this. Lack of data on whether K4 or 
K5 was recorded complicates any attempt to model the effect of this difference on the 
hypertension prevalence difference. Given that hypertension is the outcome in this study, the 
effect of the use of K4 instead of K5 is only relevant at the cutpoint of 90 mm Hg. We 
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conducted a sensitivity analysis similar to that done for the effect of zero end-digit 
preference. We changed all diastolic BP observations at 90–88 mm Hg and calculated the 
prevalence of hypertension after imputation, modeling the effect of an extreme assumption 
that all diastolic measurements recorded as 90 mm Hg were measurements of K4 and the 
corresponding level of K5 would have been <90 mm Hg. The prevalence of hypertension in 
1976–1980 showed a moderate decrease from 33.9 to 32.0% and in 1999–2002 from 25.3 to 
24.5%.
The 1988 American Heart Association recommendations for BP measurement included 
corrections for BP not measured with appropriate cuff size based on a study by Maxwell and 
coauthors.18,19 They developed correction equations for measurements by three cuffs: 12-
cm, 15-cm, and 18-cm. In 1999–2002, five cuffs were available: 6-cm, 9-cm, 12-cm, 15-cm, 
and 18-cm. In 1976–1980 only two cuffs were used: 9-cm and 12-cm. In 1976–1980, 32.4% 
of participants had arm circumferences >33 cm, the upper acceptable circumference for a 
12-cm cuff according to the 1988 American Heart Association recommendations, and thus 
should be corrected. Larger cuffs were available in 1999–2002 and Ostchega and coauthors 
reported that correct cuff sizes were used on over 86% of participants in 1999–2000.7 We 
used Maxwell’s equations to correct all observed measurements in the 1976–1980 survey. 
Although the frequency of incorrect cuff size use is less in the 1999–2002 survey, we applied 
the same corrections to make the data more comparable.
For each cuff size the equation is based on ideal arm circumference, for example for the 12-
cm cuff an arm circumference of 30 cm is the ideal size and for a circumference of 32 cm 
the systolic BP correction would be −2 mm Hg. The majority of participants had nonzero 
corrections in both surveys; for obese persons in 1976–1980, 99.0% of systolic readings 
were corrected and 98.6% of diastolic readings; and for 1999–2002, 83.4% of systolic and 
75.2% of diastolic readings.
In 1976–1980, 26 participants were measured with the 9-cm cuff. In 1999–2002 for the one 
participant measured with the 6-cm cuff and 217 measured with the 9-cm cuff, corrections 
were made using the equation for a 12-cm cuff since the study by Maxwell and coauthors 
did not include cuffs smaller than 12-cm.
Exclusions
In 1976–1980 of the 11,864 examined adults 20–74 years old, 15 (0.1%) were missing both 
BP measurements and medication information, 33 (0.3%) were missing BMI, four (0.03%) 
were missing information on cigarette smoking, and 249 (2.1%) were missing information 
on education level. The analytic sample consisted of 11,563 participants with complete data. 
In 1999–2002 of the 8,817 examined adults 20–74 years old, 720 (8.2%) failed to complete 
the BP component, 171 (1.9%) were missing BMI, 11 (0.1%) were missing information on 
cigarette smoking, and 14 (0.2%) were missing information on education level. The analytic 
sample consisted of 7,901 participants with complete data.
Statistical methods
Analyses were conducted using SAS (version 9.1.3; SAS Institute, Cary, NC) and SUDAAN 
(version 9.0.1; Research Triangle Institute, Research Triangle Park, NC) with examined 
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sample weights and sample design variables to account for the clustered design and produce 
nationally representative estimates.20–22 Previous papers on trends in hypertension reported 
declines adjusted only for age. One of our purposes was to explore whether changes in the 
distribution of other measured characteristics explained the observed decline. Because age-
adjusted estimates formed the basis of our questions we used similarly age-adjusted 
estimates as our starting point so as not to attribute any part of the observed decline to the 
aging of the population. For both surveys, estimates were adjusted by the direct method to 
the 2000 US population using the 20-year intervals: 20–39 years, 40–59 years, and 60–74 
years. Differences between surveys in demographic characteristics were tested for statistical 
significance using t-tests, with Bonferroni adjustment for multiple comparisons.23
We modeled the association of hypertension with selected risk factors and present model 
results as predicted prevalences and differences. Log-linear regression models were used to 
calculate predictive margins with data from the two surveys combined. Predictive margins 
provide predicted prevalences based on the estimated model coefficients adjusted to the 
distribution of the covariates included in the model.8,24–27 The predicted values for each 
survey were adjusted to the combined sample distribution of covariates and adjustments 
were model-specific. The predicted values for each survey-BMI category were calculated 
using the same approach. Previous papers on trends in hypertension that reported a decline 
used estimates standardized for age with 20-year age intervals.2,8,28,29 Given that our 
purpose was to consider possible explanations for this reported decline we used similar 20-
year age-adjusted estimates as the base for comparisons.
To evaluate the effect of measurement error, we created separate models using hypertension 
status corrected for cuff size, corrected for zero end-digit preference, and using hypertension 
status corrected for both sources of measurement error; these models included age defined 
using 20-year intervals as the independent variable. We estimated predicted prevalences and 
differences after adjustment for measured risk factors with and without measurement error 
corrections. In order to examine possible variation in the prevalence difference by BMI 
category, we produced estimates by BMI for hypertension as observed and after 
measurement error correction and with adjustment for age, sex, race-ethnicity, smoking, and 
education.
RESULTS
There were differences between the two populations in some demographic characteristics 
associated with hypertension (Table 2).30 The percent of 20–29 decreased (P < 0.01), the 
percent of 40–49-year olds and 60–69-year olds increased (P < 0.01 for both comparisons), 
the percent of non-Hispanic whites decreased (P < 0.01), the percent of persons with more 
than high-school education increased (P < 0.01), and the percent of never smokers increased 
(P < 0.01). The previously noted doubling in the prevalence of obesity is reflected in the 
increases between the two populations in the two higher BMI categories (BMI ≥ 30.0). This 
change in the BMI distribution of the population might be expected to result in an increase 
in hypertension prevalence assuming the association was the same in 1999–2002 as in 1976–
1980.
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After adjusting to the age distribution of the combined survey population the difference in 
the predicted hypertension prevalence was −8.6% points (95% confidence interval (CI): 
−11.4, −5.7) and decreased after correction for measurement error (Figure 1). After 
correction for cuff size, the age-adjusted difference decreased to a difference of −5.0% 
points (95% CI: −7.8, −2.3). Correction for zero end-digit preference in both surveys 
reduced the difference to −7.3% points (95% CI: −10.1, −4.4). After correction for both 
sources of measurement error, the estimated age-adjusted difference was −4.8% points, 95% 
CI: −7.5, −2.0).
The decrease in the predicted prevalence difference after correction for cuff size was 
primarily due to a lowering of the predicted prevalence estimate for 1976–1980 (Table 3). 
The larger cuff size corrections seen for the 1976–1980 estimates were because of 
unavailability of larger cuff sizes. Arm circumference was correlated with BMI and thus the 
corrections for incorrect cuff size were larger for overweight and obese persons measured 
with an incorrect cuff. For adults 20–74 years, the mean arm circumference was 31.3 cm in 
1976–1980 and 33.0 cm in 1999–2002 and increased with BMI level in both surveys.
The observed prevalence difference was larger after adjustment for BMI and age (−14.7 
points, 95% CI: −17.6, −11.7) than after adjustment for age alone (Figure 2). This was 
primarily due to a rise in the predicted prevalence for 1976–1980 from 33.9 to 37.7% (Table 
3). This result was in contrast to what one might have expected after adjustment for BMI and 
age and suggests that the association of obesity and hypertension was different in 1976–
1980 and in 1999–2002. The interaction of survey and BMI was tested using the Satterwaite-
adjusted F-test with models using hypertension before and after correction for measurement 
error and produced P values of 0.01 and 0.45, respectively. This indicates that after 
correction for measurement error the association of obesity and hypertension did not differ 
between surveys. Adjustment for sex, race-ethnicity, and education level made little 
difference in the prevalence or prevalence differences compared to the age-adjusted rates.
After adjustment for all the putative risk factors combined (BMI, age, sex, race-ethnicity, 
smoking, and education) the predicted difference in hypertension prevalence between 
surveys was larger than after adjustment for age alone but similar to the adjustment for BMI 
and age (−14.0 points, 95% CI: −16.9, −10.9). This increase in the predicted difference was 
also seen when using hypertension prevalence corrected for measurement error (−8.0 points, 
95% CI: −10.8, −5.1).
Given our a priori interest in understanding the trends in hypertension with the increase in 
obesity prevalence across surveys, we estimated the predicted prevalence of hypertension 
within the five BMI categories after adjusting for sex, race-ethnicity, age, education, and 
smoking (Table 4). We found that the prevalence of hypertension increased with increasing 
BMI category in both surveys before and after correction for measurement error. Without 
measurement error corrections the difference in hypertension prevalence between surveys 
tended to be larger in overweight and obese subjects than in those who were underweight or 
normal weight. After correction for measurement error the difference between surveys was 
more similar between overweight and obese subjects and normal weight subjects.
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The decline in the prevalence of hypertension was only partially explained by measurement 
error due to cuff size or end-digit preference and by differences in the distribution of BMI, 
sex, age, race-ethnicity, education, or smoking between surveys. The decline in hypertension 
reported from the NHANES has been reported in other studies as well. A decline in 
hypertension was reported between 1980–1982 and 1985–1987 in the Minnesota Heart 
Survey and similar trends in BP in Finland were reported between 1982 and 1987.31,32 In 
Australia, the prevalence of hypertension decreased between 1980 and 1989 primarily due to 
a decrease in undiagnosed hypertension.33
Unmeasured or unidentified changes in the US population between the two time periods 
may further explain the decline in the prevalence of hypertension. Dietary intake is one 
behavior that was measured in the surveys, but differences in the methodologies used made 
standardization across surveys difficult. 34 Beneficial changes in diet are not likely given 
analysis of NHANES trends reported for 1971–2000 for the total US population of increased 
sodium intake and no increase in intake of fruits, vegetables, or low-fat dairy foods.34 In 
addition, recent analysis of NHANES data from 1988 to 1994 and 1999 to 2004 suggest that 
the percentage of hypertensive persons following a Dietary Approaches to Stop 
Hypertension trail (DASH)-accordant diet has decreased.35 In addition, a decline in the 
proportion of adults with no leisure-time physical activity was reported for the time period 
from 1988 to 2000.36
Limitations of this study include inability to adjust for several methodologic differences 
between the surveys. More intensive and frequent training for BP measurement was 
conducted in 1999–2002 than in 1976–1980. The most recent recommendations for BP 
measurement from the American Heart Association identified end-digit preference as a 
commonly used indicator of measurement quality.37 The high prevalence of zero end digits 
in the 1976–1980 data suggest the amount and quality of training during that survey was less 
than subsequent NHANES surveys which included improved standardization of training 
reflected in lower proportions of zero end digits.2,7 The prevalence differences were 
attenuated after correction for cuff size, due to lowering of the 1976–1980 estimates. This 
underscores the importance of the use of appropriate techniques and equipment in measuring 
BP. It is possible that the correction equations were not appropriate. The study by Maxwell 
and coauthors was based on BP measured in a sample of 1,240 obese patients enrolled in a 
rapid weight loss study.19 As far as we are aware the equations have not been validated 
elsewhere. In addition our corrections did not take into account the variability of the 
equations. The adjustment equations developed by Maxwell and coauthors have been 
applied in recent NHANES analyses and confirmation of these adjustment equations would 
be an important contribution.38,39
We found that adjusting for the distribution of BMI in the combined survey population 
increased the difference in the prevalence of hypertension between the two surveys. This was 
true even after correction for measurement error. This indicates that obese persons (BMI 
≥30.0) in 1999–2002 had a lower rate of hypertension than obese persons in 1976–1980. The 
similarity in the decline in hypertension in normal weight and obese persons after correction 
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for measurement error suggests a change in some factor or factors that affected all persons 
regardless of BMI. Furthermore, we found that the observed prevalence difference increased 
with increasing BMI, however after adjustment for measurement error the differences were 
more similar.
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Predicted prevalence difference between 1999–2002 and 1976–1980 (95% confidence 
interval) for hypertension in adults 20–74 years with corrections for measurement error.
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Predicted prevalence difference between 1999–2002 and 1976–1980 (95% confidence 
interval) for hypertension in adults 20–74 years with corrections for measurement error and 
adjustment for age, body mass index (BMI), sex, race-ethnicity, smoking, and education.
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Table 2
Percent (s.e.) with selected demographic characteristics
1976–1980 1999–2002
Age in years
 20–29 27.8 (0.65) 20.3 (0.79)a
 30–39 20.5 (0.55) 22.9 (0.91)
 40–49 16.8 (0.42) 23.5 (0.75)a
 50–59 16.7 (0.45) 17.2 (0.65)
 60–69 13.6 (0.38) 11.3 (0.53)a
 70–74 4.6 (0.28) 4.8 (0.25)
Body mass index
 <18.5 3.3 (0.16) 2.0 (0.18)a
 18.5–24.9 50.8 (0.81) 33.0 (0.75)a
 25.0–29.9 31.4 (0.62) 34.2 (0.85)
 30.0–34.9 10.1 (0.36) 17.9 (0.57)a
 ≥35.0 4.4 (0.16) 13.0 (0.68)a
Sex
 Male 47.6 (0.50) 48.5 (0.49)
 Female 52.4 (0. 50) 51.5 (0.49)
Race-ethnicity
 Non-Hispanic white 82.6 (1.40) 70.4 (1.78)a
 Non-Hispanic black 10.0 (1.25) 11.2 (1.23)
 Other 7.3 (0.98) 18.4 (2.11)a
Cigarette smokingb
 Never 40.0 (0.64) 50.3 (1.23)a
 Former 22.9 (0.46) 24.0 (0.87)
 Current 37.1 (0.62) 25.7 (0.90)a
Education
 <High school 32.7 (0.97) 23.5 (1.25)a
 High school 35.6 (0.83) 25.8 (1.92)a
 >High school 31.6 (1.08) 50.7 (2.22)a
All estimates other than age-specific estimates were adjusted by the direct method to the 2000 US population using the following age groups: 20–
39 years, 40–59 years, and 60–74 years.
a
Differences between 1976–1980 and 1999–2002 were statistically significant at P < 0.01, the α-level reflecting adjustment for multiple 
comparisons.
b
In both surveys smoking status was categorized as never smokers (defined as persons who reported not smoking at least 100 cigarettes in their 
life), former smokers (defined as persons who reported smoking at least 100 cigarettes in their life but were not currently smoking), and current 
smokers (defined as persons who reported smoking at least 100 cigarettes in their life and were currently smoking).
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Table 3
Predicted prevalence of hypertension in adults 20–74 years with corrections for measurement error and 
adjustment for age, sex, race-ethnicity, education, smoking, and body mass index (BMI)
Model
Predicted prevalencea of hypertension (s.e.)
Without adjustment for cuff size and end-
digit preference
With adjustment for cuff size and end-digit 
preference
1999–2002 1976–1980 1999–2002 1976–1980
Age (in 20-year intervals) 25.3 (0.91) 33.9 (1.12) 25.5 (0.88) 30.3 (1.08)
Age (in 20-year intervals) + sex 25.3 (0.91) 33.9 (1.12) 25.5 (0.88) 30.3 (1.09)
Age (in 20-year intervals) + race-
ethnicity
25.2 (0.92) 34.0 (1.10) 25.4 (0.90) 30.4 (1.07)
Age (in 20-year intervals) + education 25.7 (0.90) 33.0 (1.16) 25.9 (0.87) 29.4 (1.11)
Age (in 20-year intervals) + sex + race-
ethnicity + education
25.4 (0.91) 33.5 (1.16) 24.3 (0.84) 32.3 (1.19)
Age (in 20-year intervals) + smoking 25.2 (0.92) 34.1 (1.12) 25.4 (0.89) 30.5 (1.09)
Age (in 20-year intervals) + BMI 23.0 (0.84) 37.7 (1.24) 24.1 (0.82) 32.8 (1.19)
Age (in 5-year intervals) + sex + race-
ethnicity + education + smoking + BMI
23.2 (0.84) 37.2 (1.30) 24.3 (0.84) 32.3 (1.19)
a
All differences between 1976–1980 and 1999–2002 were statistically significant at P < 0.01.
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Table 4
Predicted prevalence (percent) of hypertension in adults 20–74 years by body mass index (BMI) category with 
corrections for measurement error and adjustment for age, sex, race-ethnicity, education, and smoking
Without adjustment for cuff size and end-digit preference With adjustment for cuff size and end-digit preference
1999–2002 1976–1980 1999–2002 1976–1980
BMI
 <18.5 15.9 (3.54) 11.8 (2.38) 17.4 (3.86) 16.9 (2.66)
 18.5–24.9 13.1 (0.97) 20.7 (1.07) 15.0 (1.06) 21.5 (1.07)
 25.0–29.9 25.5 (1.49) 41.3 (1.66) 26.0 (1.26) 34.6 (1.51)
 30.0–34.9 35.6 (1.40) 55.4 (2.23) 35.2 (1.40) 42.7 (1.91)
 ≥35.0 44.7 (2.37) 67.2 (2.64) 43.8 (2.06) 52.5 (2.10)
Separate models for each BMI group included adjustment for age, sex, race-ethnicity, education, and smoking. All differences between 1976–1980 
and 1999–2002 were statistically significant at P < 0.01.
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